Search results for: 'Well owners and testing'
- Did you mean
- well owners ad testing
- Related search terms
- AND (SELECT (CASE WHEN (3989=1399) THEN NULL ELSE CTXSYS.DRITHSX.SN(1,3989) END) FROM DUAL) IS NULL
- AND (SELECT (CASE WHEN (4327=4327) THEN NULL ELSE CTXSYS.DRITHSX.SN(1,4327) END) FROM DUAL) IS NULL
- AND (SELECT (CASE WHEN (1509=3753) THEN NULL ELSE CTXSYS.DRITHSX.SN(1,1509) END) FROM DUAL) IS NULL-- wUvH
- AND (SELECT 1827 FROM (SELECT(SLEEP(20)))zydf)
- wellness and beauty united arab emirates
-
03 Oct 2022  |  Global  |  Market Research
Global Prenatal Genetic Testing—Forecast to 2026
Innovation Culture in Screening Drives Prenatal Genetic Testing Growth and Makes it Accessible to More Patients
New technological advances in prenatal genetic testing include the enhancement of the next-generation sequencing (NGS) technology, chromosomal microarray analysis (CMA) tool, and PCR TaqMan. These improve precision and specificity in genome profiling, augment the efficiency and reliability of testing, and streamline workflow. The study will help...
$4,950.00
Special Price $3,712.50 save 25 %
-
27 Aug 2018  |  Global  |  Market Research
Growth Insights for the Direct-to-Consumer Genetic Testing Market, Forecast to 2022
Consumer Education and Exploring Alternative Markets Would Drive the Direct-to-Consumer Genetic Testing Market
As healthcare evolves toward personalized solutions, everyday consumers are proactively taking responsibility for their health in ways unimaginable a decade ago. A direct-to-consumer genetic test (DTCGT) exemplifies this trend which can be purchased and used directly by consumers without the requirement of a prescription from a healthcare provider....
$3,000.00
Special Price $2,250.00 save 25 %
-
27 Dec 2018  |  Global  |  Technology Research
Microbiome Technologies Fueling Human Health and Wellness
Emerging Microbiome Platforms Disrupting Pharmaceutical, Food & Beverages and the Consumer Care Industries
This research service encompasses microbiome technology trends and emerging innovations across: Disease Management This research segment explores the emerging role of microbiome-based therapeutics across a wide range of diseases, especially in the context of gastro-intestinal health, while providing strategic insights across the highly dynamic com...
$4,950.00
Special Price $3,712.50 save 25 %
-
20 Sep 2019  |  Global  |  Technology Research
Precision Immunotherapy Innovations Transforming Human Health and Wellness
A Review of Advances in Cell Therapies, Antibodies, Fusion Proteins, and Other Innovative Approaches for Cancer Treatment
There are numerous companies developing immunotherapy approaches to treat cancer, autoimmune and several other diseases. Current study describes some of the recent advances in immunotherapy, mostly cancer. These include refined cell therapies, stem cell applications in cancer treatment, monoclonal, polyclonal and bispecific antibodies. Some of exci...
$4,950.00
Special Price $3,712.50 save 25 %
-
03 Apr 2023  |  Global  |  Market Outlook
Global Next generation Diagnostics, Outlook 2023
Automation and Digitization Drive the Next Growth Phase Post-COVID-19
As COVID-19 transitions to the endemic phase, automation solutions and smart, connected laboratories will catalyze recovery in the next-generation diagnostics industry. The COVID-19 pandemic left a lot of installed capacity in laboratories and healthcare centers. To take advantage of this situation, it is necessary for industry players to focus on ...
$4,950.00
Special Price $3,712.50 save 25 %
-
06 Jun 2018  |  Global  |  Market Research
Cardiometabolic Diseases Market—Trends and Growth Opportunities, Forecast to 2022
Shift Towards a 'Comprehensive Care Continuum' with the Adoption of Integrated Care Pathways that Combine Clinical Therapies with Wellness Programs
Globally, cardiometabolic diseases are witnessing a consistent rise in prevalence every year, with hypertension and diabetes among the leading conditions. A rising population of hypertension is, in turn, leading to growing incidence of chronic heart failure with about 26 million cases of CHF globally. Although drug therapies are the first line of t...
$4,950.00
Special Price $3,712.50 save 25 %
-
12 Dec 2024  |  Global  |  Market Outlook
Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025
Approval of New Tests and Laboratory Automation Solutions are Driving Transformational Growth
Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and translation of blood-based neurology biomarkers, sustai...
$2,450.00
Special Price $2,082.50 save 15 %
-
20 Jan 2025  |  Global  |  Market Research
Global Cardiac Biomarkers Diagnostics Industry, 2024-2029
Rising Prevalence of CVD and High Sensitivity POCT Driving Transformational Growth in Cardiac Biomarkers Diagnostics
The global cardiac biomarkers diagnostics market is forecast to record robust growth with the increased prevalence of cardiovascular disease (CVD), multiplex biomarkers, advancements in diagnostic testing technology, higher POCT adoption rates, and an intensive focus on preventive healthcare. CVDs are a leading cause of mortality globally, highligh...
$4,950.00
Special Price $4,207.50 save 15 %
-
29 Aug 2022  |  Global  |  Technology Research
Advancements in miRNA: Technology Assessment
Developments in miRNA sequencing and analysis are driving future growth potential in therapeutics and diagnostics
Accelerated research around RNA-based therapeutics and diagnostics, accompanied by technology advancements in sequencing the human genome, has resulted in a better understanding of the role of miRNA in biological pathways, enhancing its potential in both therapeutics and diagnostics. The successful clinical validation of miRNA diagnostic tests has ...
$4,950.00
Special Price $3,712.50 save 25 %
-
27 Aug 2020  |  Global  |  Market Research
Smart Labs as Key Drivers for the Digital Transformation of Diagnostic Laboratories, 2020
Robotic Automation, Internet of Things (IoT), and Artificial Intelligence (AI) Offering Growth Opportunities for Academic and Commercial Diagnostics Labs
Diagnostic academic and commercial research labs suffer from cost pressures, given the ongoing Protecting Access to Medicare Act (PAMA) regulations and reproducibility issues, and are under productivity strain. The recent COVID-19 pandemic leading to increasing test volumes and renewed focus on research and development (R&D) to drive innovation wil...
$3,000.00
Special Price $2,250.00 save 25 %